Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Nathrath

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Journal of Neuro-Oncology|February 13, 2015
Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]Matthias Preuss, Holger Christiansen, Andreas Merkenschlager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2010
Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcomaJan Smida, Daniel Baumhoer, Michael Rosemann, et al.
Cancers|January 23, 2024
Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study GroupVanessa L Mettmann, Claudia Blattmann, Godehard Friedel, et al.
Pediatric Blood & Cancer|April 27, 2012
Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS)Tobias M Dantonello, Ivo Leuschner, Christian Vokuhl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantationVanya Icheva, Simone Kayser, Daniel Wolff, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Journal of Medical Genetics|March 18, 2020
Germline <i>RET</i> variants underlie a subset of paediatric osteosarcomaMichal Kovac, Connor Woolley, Sebastian Ribi, et al.
Pediatric Blood & Cancer|September 30, 2024
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Stefanie Hecker-Nolting, et al.
The Journal of Pathology|December 15, 2018
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of boneDaniel Baumhoer, Michal Kovac, Jan Sperveslage, et al.
Cancer Medicine|September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neuro-Oncology|February 13, 2015
Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]Matthias Preuss, Holger Christiansen, Andreas Merkenschlager, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2010
Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcomaJan Smida, Daniel Baumhoer, Michael Rosemann, et al.
Cancers|January 23, 2024
Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study GroupVanessa L Mettmann, Claudia Blattmann, Godehard Friedel, et al.
Pediatric Blood & Cancer|April 27, 2012
Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS)Tobias M Dantonello, Ivo Leuschner, Christian Vokuhl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantationVanya Icheva, Simone Kayser, Daniel Wolff, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Journal of Medical Genetics|March 18, 2020
Germline <i>RET</i> variants underlie a subset of paediatric osteosarcomaMichal Kovac, Connor Woolley, Sebastian Ribi, et al.
Pediatric Blood & Cancer|September 30, 2024
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Stefanie Hecker-Nolting, et al.
The Journal of Pathology|December 15, 2018
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of boneDaniel Baumhoer, Michal Kovac, Jan Sperveslage, et al.
Cancer Medicine|September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Pageof 9